Fig. 4.

Current clinical strategies in pancreatic cancer. For patients with pancreatic cancer, the primary clinical strategies rely on chemotherapy, whereas novel therapeutic agents targeting DNA repair, gene mutations, tumor metabolism, tumor microenvironments, or immune checkpoints might improve their prognosis. Currently, increasing interest has emerged in combined chemotherapy and immunotherapy or targeted therapy